title: Risk management and post-marketing surveillance of CNS drugs: an introduction.
authors.forename: Robert L
authors.initials: RL
authors.lastname: Balster
authors.forename: Chris-Ellyn
authors.initials: CE
authors.lastname: Johanson
authors.forename: Sharon L
authors.initials: SL
authors.lastname: Walsh
mesh_terms: D002491:Central Nervous System Agents / Q000009:adverse effects*; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence; D006801:Humans; D011358:Product Surveillance, Postmarketing / Q000639:trends*; D012308:Risk Management / Q000331:legislation & jurisprudence*; D019966:Substance-Related Disorders / Q000453:epidemiology / Q000517:prevention & control
chemical_list: D002491:Central Nervous System Agents